CRANBURY, N.J., Oct. 22, 2025 \u2014 MJH Life Sciences, the largest privately held medical media company in North America, today announced the acquisition of BPD Healthcare, the leading tech-enabled comprehensive marketing and communications partner delivering transformational results to healthcare\u2019s leading institutions. The expansion broadens MJH\u2019s offerings and builds upon its rich history of collaboration with hospitals and health systems through its Strategic Alliance Partnership (SAP) program to provide better care to patients.<\/p>\n
Together, MJH Life Sciences and BPD bring a powerful combination of reach, insight, and strategic capabilities to healthcare\u2019s most trusted brands and stakeholders. MJH\u2019s deep relationships with clinicians, researchers and healthcare organizations complement BPD\u2019s expertise in helping those organizations expand, engage, and evolve through the dynamic challenges impacting patient care. Combining BPD Healthcare\u2019s data-driven strategy and communications with MJH Life Sciences\u2019 industry-leading healthcare content and engagement, the partnership creates a new model for how innovation moves through the healthcare system faster, smarter and with greater impact for patients.<\/p>\n
\u201cThis is about building a powerful bridge between the science that transforms lives and the systems that deliver that transformation,\u201d said Michael J. Hennessy Jr., chairman and CEO of MJH Life Sciences. \u201cBPD shares our unwavering belief that when innovation meets communication, healthcare moves forward. Together, we\u2019re not just connecting information, we\u2019re accelerating how health systems, hospitals, and organizations reach patients and redefine what state-of-the-art care looks and feels like.\u201d<\/p>\n
BPD serves as a strategic growth partner to many of the nation\u2019s leading health systems, academic medical centers, and healthcare innovators. The company partners with clients to provide fully integrated solutions \u2013 branding, marketing, communications, and business consulting \u2014 that are technology-enabled, AI-infused, and supported by a proprietary data platform. BPD helps healthcare stakeholders solve the C-suite\u2019s biggest challenges, including market assessments, patient acquisition, physician referrals, reputation management, payor negotiations, talent recruitment and team engagement.<\/p>\n
\u201cHealthcare is changing faster than ever, and the organizations that thrive will be the ones that connect meaning with action,\u201d said Jason Brown, CEO of BPD. \u201cJoining MJH Life Sciences allows BPD to bring that connection to life on a much larger scale. Together, we can help our clients not just grow their brands but strengthen and innovate the industry to better care for patients and communities.\u201d<\/p>\n
BPD will continue to operate independently under the BPD Healthcare brand, as a wholly owned subsidiary of MJH Life Sciences. Jason Brown will remain CEO of BPD, reporting directly to Michael J. Hennessy Jr. The alignment with MJH Life Sciences will further enhance BPD\u2019s ability to deliver integrated, data-driven solutions that create greater value for clients and their audiences.<\/p>\n
MJH Life Sciences continues to deliver industry-leading capabilities across the healthcare spectrum. The company produces more than 2,500 live and virtual events annually, from intimate peer-to-peer dinners to large-scale conferences with thousands of attendees and complex exhibit halls. It also houses over 330 hours of video content produced through its state-of-the-art studio in Cranbury, New Jersey, as well as through additional studios nationwide. MJH maintains strong partnerships with more than 800 associations, advocacy groups, academic medical systems and community cancer centers, along with trusted relationships with hundreds of thought leaders, researchers and medical directors across multiple specialties.<\/p>\n
The acquisition of BPD positions MJH Life Sciences to deliver an even more comprehensive suite of solutions that empower healthcare organizations to grow, innovate and measure impact. This advances MJH Life Sciences\u2019 long-standing commitment to improving patient care and outcomes through data-rich capabilities.<\/p>\n
Houlihan Lokey and William Blair acted as financial advisers and McDermott Will & Schulte provided legal representation to BPD. Day Pitney provided legal representation to MJH.<\/p>\n
About MJH Life Sciences\u00ae About BPD Media Contacts:<\/p>\n Becca Fishman
MJH Life Sciences is the largest privately held medical media company in North America, dedicated to improving patient care through trusted health care communications, education, and research. We reach over 7 million health care decision-makers\u2014including physicians, pharmacists, and managed care professionals\u2014delivering essential insights across digital, print, and live platforms. With a diverse portfolio of leading brands, events, and multimedia solutions, we connect health care professionals with the latest advancements and expert perspectives. Committed to driving meaningful change in health care, we strive to make an impact through innovation and excellence. For more information about MJH, visit\u00a0https:\/\/www.mjhlifesciences.com\/<\/a>.<\/p>\n
BPD is a strategic growth partner that delivers the future to healthcare\u2019s leading brands. We provide fully integrated solutions \u2014 branding, marketing, communications, and business consulting \u2014 that are technology-enabled, AI-infused, and supported by our proprietary data platform. All this is done to ignite greatness in our clients and bring better health to more people. Our clients include the largest health systems, prestigious academic medical centers, care delivery enablers, multilocation provider practices, and leading healthcare innovators. For more information on BPD, visit www.bpdhealthcare.com<\/a>.<\/p>\n
[email\u00a0protected]<\/a><\/p>\n